Nanovector delivery of siRNA for cancer therapy.

Cancer Gene Therapy
H ShenMauro Ferrari

Abstract

RNA interference holds the promise to knock down expression of every cancer gene. Both academic laboratories and pharmaceutical companies have committed heavily on manpower and financial resources to develop small interfering RNA (siRNA) cancer therapeutics over the last decade. Although significant advances have been made in the design of siRNA therapeutics and mechanism of action on cancer cell killing, there are still many hurdles to overcome including effective delivery of therapeutics in vivo. Nanotechnology has had an important role in the development of delivery vectors so far. This article summarizes current nanovectors for siRNA delivery, discusses technical challenges in overcoming biological barriers, and introduces the multistage vector system for tumor-specific delivery.

References

Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Feb 7, 2001·Genes & Development·S M ElbashirT Tuschl
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·A PluenR K Jain
Nov 10, 2001·Annual Review of Biomedical Engineering·R K Jain
Nov 13, 2004·Nature·Jürgen SoutschekHans-Peter Vornlocher
Jan 22, 2005·Current Opinion in Genetics & Development·Peter BalukDonald M McDonald
Mar 22, 2005·Nature Biotechnology·Adam D JudgeIan MacLachlan
Jul 26, 2005·Nature Biotechnology·David V MorrisseyBarry Polisky
Mar 28, 2006·Nature·Tracy S ZimmermannIan MacLachlan
Mar 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jeremy D HeidelMark E Davis
Apr 5, 2007·Nature Protocols·Mohammed AmarzguiouiJohn J Rossi
Jul 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·David B RozemaJon A Wolff
Sep 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Derek W BartlettMark E Davis
Oct 13, 2007·Science·Laura D WoodBert Vogelstein
Oct 16, 2007·Biomaterials·Paolo Decuzzi, Mauro Ferrari
Dec 22, 2007·Expert Opinion on Drug Delivery·David B Fenske, Pieter R Cullis
Mar 28, 2008·Nature·Mark E KleinmanJayakrishna Ambati
Apr 29, 2008·Nature Biotechnology·Akin AkincDaniel G Anderson
Feb 21, 2009·The Journal of Clinical Investigation·Adam D JudgeIan MacLachlan
Mar 5, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Akin AkincDaniel G Anderson
Jun 17, 2009·ACS Nano·Gary B BraunNorbert O Reich
Jul 22, 2009·The Journal of Clinical Investigation·Juan R Cubillos-RuizJose R Conejo-Garcia
Sep 17, 2009·The AAPS Journal·Sherry Y Wu, Nigel A J McMillan
Oct 31, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·P DecuzziM Ferrari
Nov 12, 2009·Nanotechnology·Sei-Young LeePaolo Decuzzi
Jan 12, 2010·Journal of Internal Medicine·B OzpolatG Lopez-Berestein
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Kevin T LoveDaniel G Anderson
Feb 27, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Myung Sook HuhIck Chan Kwon
May 1, 2010·Cancer Research·Takemi TanakaMauro Ferrari
Feb 9, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hye-Sun KimAnil K Sood
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Jun 21, 2011·Nature Materials·Geoffrey von MaltzahnSangeeta N Bhatia
Sep 10, 2011·Accounts of Chemical Research·Biana GodinMauro Ferrari

❮ Previous
Next ❯

Citations

Oct 10, 2013·EMBO Molecular Medicine·Kerstin B KaufmannManuel Grez
Jun 18, 2014·Molecular Therapy. Nucleic Acids·Jiehua Zhou, John J Rossi
Jul 12, 2013·BioMed Research International·Jong-Min LeeYoung-Seok Cho
Feb 7, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Haifa ShenGabriel Lopez-Berestein
Oct 2, 2013·Journal of Drug Targeting·Burcu AslanGabriel Lopez-Berestein
Oct 5, 2013·Expert Opinion on Drug Delivery·Roberto MolinaroMassimo Fresta
Nov 27, 2015·Advanced Materials·Mijanur Rahaman Molla, Pavel A Levkin
Feb 4, 2016·Wiley Interdisciplinary Reviews. RNA·Adele Alagia, Ramon Eritja
Feb 6, 2013·Biomaterials·Kirk K HouSamuel A Wickline
May 29, 2012·Advanced Drug Delivery Reviews·Hamsa Jaganathan, Biana Godin
Dec 29, 2015·Cellular and Molecular Life Sciences : CMLS·Nidhi Sharma, Sushmita Jha
Sep 15, 2015·International Journal of Biological Macromolecules·Farnaz Sadat Mirzazadeh TekieRassoul Dinarvand
Aug 13, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joy WolframMauro Ferrari
Mar 10, 2016·Journal of Nanobiotechnology·Sten Friberg, Andreas M Nyström
Oct 9, 2014·Angewandte Chemie·Tianmeng SunYounan Xia
Jul 15, 2015·Future Oncology·Sten Friberg, Andreas M Nyström
Feb 4, 2014·Biochemical and Biophysical Research Communications·Rian M HassonNancy L Cho
May 6, 2014·Frontiers in Pharmacology·Aditi M Jhaveri, Vladimir P Torchilin
Oct 11, 2012·Immunotherapy·Soudeh Ghafouri-Fard, Somayyeh Ghafouri-Fard
May 26, 2016·Molecular Pharmaceutics·Sara MovassaghianOlivia M Merkel
Jul 11, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Bronwyn ScottJoy Wolfram
Oct 24, 2014·Molecular Pharmaceutics·A LakshmikuttyammaS A Shoyele
Oct 1, 2016·Expert Opinion on Drug Delivery·Ayesha KhalidJoy Wolfram
Oct 21, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yujing LiLesheng Teng
Nov 9, 2016·Methodist DeBakey Cardiovascular Journal·Wing Tak WongHaifa Shen
Apr 21, 2017·Artificial Cells, Nanomedicine, and Biotechnology·Aishwarya SinghNarendra Kumar Jain
Apr 11, 2017·ACS Applied Materials & Interfaces·Silvia MinardiEnnio Tasciotti
Feb 5, 2015·Revista da Associação Médica Brasileira·José Ednésio da Cruz FreireLéa Maria Bezerra de Menezes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.